Balaji Venugopal, MBBS MD


Advanced Penile Cancer Presenting With Renal Failure

“MK,” a man aged 67 years, presented with fatigue and nausea to his primary care physician. CT staging scans confirmed the primary tumor and a suspicious left 1.2-cm inguinal lymph node but no distant metastases. MRI of the pelvis revealed complete replacement of the penis with tumor as well as invasion into the scrotum and bilateral groin soft tissue; additionally, early pubic bone invasion was present, with left groin lymphadenopathy. Biopsy verified squamous cell carcinoma of the penis, and discussion with the multidisciplinary team uroradiologist confirmed bony invasion.

Hans Hammers, MD


Renal Cell Carcinoma: Practical Advice for Patients, Caregivers, and Physicians

Practical advice on the management of renal cell carcinoma provided for healthcare professionals, patients, and caregivers alike.

Craig Hofmeister, MD, MPH


Optimizing Therapy in Frontline Multiple Myeloma Not Eligible for Transplant

Experts in the multiple myeloma field discuss which front-line therapy is best for patients who are treatment ineligible.

Tony S. Mok, MD


Tony S. Mok, MD, Reviews Importance of Adjuvant Nivolumab in Resectable NSCLC

Tony S. Mok, MD, spoke about utilizing adjuvant or neoadjuvant treatment for patients with non–small cell lung cancer.

Melissa M. Shaw, MD


Association of Financial Conflicts of Interest With Academic Productivity Among Junior Faculty in Hematology and Oncology

Conflicts of interest for junior faculty members were evaluated at top cancer centers by Suneel D. Kamath, MD, et al. to determine how financial conflicts of interest correlated with measures of academic career productivity.

Jing Han, MD


Ocular Toxicities of MEK Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis

Jing Han, MD, and colleagues examine the prevalence and characteristics of ocular toxicities associated with MEK inhibition.

Vidya G Doddawad, BDS, MDS


Exploring the Changing Diagnostic Criteria of Gorlin-Goltz Syndrome: A Case Report

A case study by Sahith Kumar Shetty, BDS, MDS, et al reviews the need for a multidisciplinary approach to the treatment of patients with Gorlin-Goltz syndrome.

Beth Faiman, PhD, MSN, APN-BC


Clinical Practice Perspectives on Treatment of MM with Bispecifics

Before closing out their discussion on multiple myeloma management, panelists reflect on real-world clinical practice perspectives on treatment with bispecifics.

Brandon Sheffield, MD


Brandon Sheffield, MD, Details NGS Benefits Vs Single-Gene Testing in NSCLC

At the 2022 WCLC, Brandon Sheffield, MD, presented data demonstrating the advantage of next-generation sequencing over other biomarker testing strategies in patients with non–small cell lung cancer.

Apar Kishor Ganti, MD


Factors Associated With Treatment Refusal and Impact of Treatment Refusal on Survival of Patients With Small Cell Lung Cancer

Original research published in the journal ONCOLOGY® explored the impacts of treatment refusal in patients with small cell lung cancer.

Liwei Jia, MD, PhD


Management of Testicular Germ Cell Tumor With Somatic-Type Malignancy

In this installment of Clinical Quandaries, Bendu Konneh, BS, and colleagues present a case of a 21-year-old male with a 4-month history of progressive swelling in the right testicle.

Chung-Han Lee, MD, PhD, Memorial Sloan Kettering Cancer Center


Value of Collaboration in Managing Patients With Metastatic RCC

Closing out their discussion on the management of metastatic renal cell carcinoma, panelists highlight the value of collaborative care in improving patient outcomes.

Alex Biese


Stress Management App Helps to Improve Mental Health in Those With Cancer

Results from the RESTORE study indicate that a cognitive behavioral stress management app improves symptoms of anxiety and depression.

Yoon-Koo Kang, MD, PhD


Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma

Daniel V. T. Catenacci, MD, and colleagues present findings from a study of circulating tumor DNA as a predictive biomarker for gastric and gastroesophageal cancer.

Peter Humphrey MD, PhD


Peter Humphrey, MD, PhD, Discusses Current Role of Pathology in RCC

At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Peter Humphrey, MD, PhD, spoke about the role of pathology in renal cell carcinoma.

Saad Z. Usmani, MD, MBA, FACP


Managing Hematological Toxicities Associated with Bispecifics in MM

Experts on multiple myeloma provide insights on the management of hematological toxicities associated with bispecific antibodies.